Provides marketing promotion services to insurance carriers and intermediaries, and sells medical devices to dealers and hospitals.
20-F for FY2026, filed Jul 23, 2026For the years ended March 31, 2026 2025 2024 Revenues Revenue from sale of medical devices $ — $ 415,020 $ 2,416,797 Revenue from marketing…View ↗
Our clients are well-known insurance carriers and insurance intermediaries in China. At present, we have established cooperation with…View ↗
Our medical devices business which includes the sale of defibrillators and anesthesia laryngoscopes primarily target medical product…View ↗
Insurance carriers and intermediaries pay for marketing promotion services through fees based on orders, which are charged weekly.
20-F for FY2026, filed Jul 23, 2026
$13.8M
20-F for FY2026, filed Jul 23, 2026
$13.8M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Revenue
Usage-based
20-F for FY2026, filed Jul 23, 2026 |
100%
FY2023: 100%
|
Revenue, FY2026
$13.8M Sources
|
Usage-based |
|
Tax and surcharges
|
0.0%
FY2023: 0.0%
|
Tax and surcharges, FY2026
−$3.2K Sources
|
Insurance carriers and insurance intermediaries in China buy marketing promotion services directly under cooperation agreements that typically last two or three years.
20-F for FY2026, filed Jul 23, 2026
20-F for FY2026, filed Jul 23, 2026
For the year ended March 31, 2026, three customers accounted for 31.9%, 20.6% and 10.5% for the Company’s total revenue from sales of…View ↗
No. It lost $18.7M in FY2026.
20-F for FY2026, filed Jul 23, 2026
−$20.7MView ↗
20-F for FY2026, filed Jul 23, 2026
−$18.7MView ↗
20-F for FY2026, filed Jul 23, 2026
−$12.8MView ↗
Growing. Revenue grew 2.3x in 4 years, from $6M in FY2022 to $13.8M in FY2026, about 23% a year.
From social commerce to healthcare
The older report described social e-commerce alongside cancer-care plans and COVID test sales; the latest says social e-commerce was disposed of and describes medical-device sales, marketing-promotion services, and online hospital operations.
20-F for FY2023, filed Jul 14, 2023 20-F for FY2026, filed Jul 23, 2026Historically, the Company generated revenues primarily from our loan facilitation services, post-origination services, and other related…View ↗
Recently, we advanced our presence in online hospital and chain pharmacies segments in China. In November 2024, we completed the…View ↗
On March 5, 2024, Tianjin Akso Enterprise Management Co., Ltd., our PRC subsidiary, entered into certain securities purchase agreements…View ↗
Loading...